120 related articles for article (PubMed ID: 32968452)
1. Establishment and characterization of a docetaxel-resistant human prostate cancer cell line.
Liu J; Huang Y; Zhu D; Dai Y; Liu D; Zhai Y; Liang X; Wu L; Zhao Q
Oncol Lett; 2020 Nov; 20(5):230. PubMed ID: 32968452
[TBL] [Abstract][Full Text] [Related]
2. Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance.
Huang Y; Zhai Y; Wu M; Chang C; Luo J; Hong D; Zhao Q; Dai Y; Liu J
Drug Des Devel Ther; 2022; 16():3817-3828. PubMed ID: 36388085
[TBL] [Abstract][Full Text] [Related]
3. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
Qian S; Zhang S; Wu Y; Ding Y; ; Li X
Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p/JAG1 pathway.
Ma Y; Fan B; Ren Z; Liu B; Wang Y
Onco Targets Ther; 2019; 12():5485-5497. PubMed ID: 31371987
[No Abstract] [Full Text] [Related]
5. Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds.
Ahmed IA; Hafiz S; van Ginkel S; Pondugula SR; Abdelhaffez AS; Sayyed HG; El-Aziz EAA; Mansour MM
Nat Prod Commun; 2023 May; 18(5):. PubMed ID: 37292146
[TBL] [Abstract][Full Text] [Related]
6. [Effects of silencing HMGB1 combined with docetaxel chemotherapy on the proliferation and apoptosis of prostate cancer cells and its action mechanism].
Feng WB; Chen C
Zhonghua Nan Ke Xue; 2021 Oct; 27(10):876-881. PubMed ID: 34914264
[TBL] [Abstract][Full Text] [Related]
7. [Effect of sodium phenylbutyrate on the sensitivity of PC3/DTX-resistant prostate cancer cells to docetaxel].
Xu YW; Zheng SB; Chen BS; Wen Y; Zhu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Novemer 20; 37(1):130-134. PubMed ID: 28109113
[TBL] [Abstract][Full Text] [Related]
8. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
Sato S; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Iba T; Naniwa J; Uegaki K; Terakawa N
Cancer Chemother Pharmacol; 2004 Mar; 53(3):247-52. PubMed ID: 14610615
[TBL] [Abstract][Full Text] [Related]
9. Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer.
Lima TS; Souza LO; Iglesias-Gato D; Elversang J; Jørgensen FS; Kallunki T; Røder MA; Brasso K; Moreira JMA
Front Pharmacol; 2022; 13():869461. PubMed ID: 35721223
[TBL] [Abstract][Full Text] [Related]
10. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
[TBL] [Abstract][Full Text] [Related]
11. Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.
Kato T; Mizutani K; Kameyama K; Kawakami K; Fujita Y; Nakane K; Kanimoto Y; Ehara H; Ito H; Seishima M; Deguchi T; Ito M
Urol Oncol; 2015 Sep; 33(9):385.e15-20. PubMed ID: 26027763
[TBL] [Abstract][Full Text] [Related]
12. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
[TBL] [Abstract][Full Text] [Related]
13. Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancer.
Li YF; Ji HH; Zhang ZL; Zhang TT; Gan W; Zhang SF
Oncol Lett; 2017 Aug; 14(2):1748-1756. PubMed ID: 28789405
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
15. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
Singh SK; Lillard JW; Singh R
Cancer Lett; 2018 Jul; 427():49-62. PubMed ID: 29678549
[TBL] [Abstract][Full Text] [Related]
16. Low-dose Docetaxel Enhanced the Anticancer Effect of Temsirolimus by Overcoming Autophagy in Prostate Cancer Cells.
Inamura SO; Ito H; Taga M; Tsuchiyama K; Hoshino H; Kobayashi M; Yokoyama O
Anticancer Res; 2019 Oct; 39(10):5417-5425. PubMed ID: 31570436
[TBL] [Abstract][Full Text] [Related]
17. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.
Sekino Y; Oue N; Koike Y; Shigematsu Y; Sakamoto N; Sentani K; Teishima J; Shiota M; Matsubara A; Yasui W
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30744126
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a cisplatin‑resistant human osteosarcoma cell line.
Han T; Zhu X; Wang J; Zhao H; Ma Q; Zhao J; Qiu X; Fan Q
Oncol Rep; 2014 Sep; 32(3):1133-9. PubMed ID: 25017716
[TBL] [Abstract][Full Text] [Related]
19. circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3.
Yin H; Qin H; Yang L; Chen M; Yang Y; Zhang W; Hao J; Lu Q; Shi J; Zhuang J; Qiu X; Guo H
Biomark Res; 2022 Jul; 10(1):48. PubMed ID: 35831872
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
